Formoterol and salmeterol induce a similar degree of β2‐adrenoceptor tolerance in human small airways but via different mechanisms
Authors:
Open Access
- 10 February 2011
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 163 (3) , 521-532
Abstract
BACKGROUND AND PURPOSE: Steroids prevent and reverse salbutamol‐induced β2‐adrenoceptor tolerance in human small airways. This study examines the effects of the long‐acting β2agonists (LABAs) formoterol and salmeterol, and the ability of budesonide to prevent desensitization.EXPERIMENTAL APPROACH: Long‐acting β2agonists in the presence and absence of budesonide were incubated with human precision‐cut lung slices containing small airways. Tolerance was deduced from measurements of reduced bronchodilator responses to isoprenaline and correlated with β2‐adrenoceptor trafficking using a virally transduced, fluorescent‐tagged receptor. The ability of the LABAs to protect airways against muscarinic‐induced contraction was also assessed.KEY RESULTS: Following a 12 h incubation, both formoterol and salmeterol attenuated isoprenaline‐induced bronchodilatation to a similar degree and these effects were not reversible by washing. Pre‐incubation with budesonide prevented the desensitization induced by formoterol, but not that induced by salmeterol. Formoterol also protected the airways from carbachol‐induced bronchoconstriction to a greater extent than salmeterol. In the epithelial cells of small airways, incubation with formoterol promoted receptor internalization but this did not appear to occur following incubation with salmeterol. Budesonide inhibited the formoterol‐induced reduction in plasma membrane β2‐adrenoceptor fluorescence.CONCLUSIONS AND IMPLICATIONS: Although both formoterol and salmeterol attenuate isoprenaline‐induced bronchodilatation, they appear to induce β2‐adrenoceptor tolerance via different mechanisms; formoterol, but not salmeterol, enhances receptor internalization. Budesonide protection against β2‐adrenoceptor tolerance was correlated with the retention of receptor fluorescence on the plasma membrane, thereby suggesting a mechanism by which steroids alter β2‐adrenoceptor function.Keywords
This publication has 39 references indexed in Scilit:
- Human Airway Contraction and Formoterol-Induced Relaxation Is Determined by Ca2+ Oscillations and Ca2+ SensitivityAmerican Journal of Respiratory Cell and Molecular Biology, 2010
- Endosomes: A legitimate platform for the signaling trainProceedings of the National Academy of Sciences, 2009
- Agonist‐specific patterns of β2‐adrenoceptor responses in human airway cells during prolonged exposureBritish Journal of Pharmacology, 2009
- The long‐acting β‐adrenoceptor agonist, indacaterol, inhibits IgE‐dependent responses of human lung mast cellsBritish Journal of Pharmacology, 2009
- Sustained cyclic AMP production by parathyroid hormone receptor endocytosisNature Chemical Biology, 2009
- Persistent cAMP-Signals Triggered by Internalized G-Protein–Coupled ReceptorsPLOS Biology, 2009
- Vitamin D and glucocorticoids differentially modulate chemokine expression in human airway smooth muscle cellsBritish Journal of Pharmacology, 2008
- Evidence of the in vivo esterification of budesonide in human airwaysBritish Journal of Clinical Pharmacology, 2008
- Salmeterol Stimulation Dissociates β2-Adrenergic Receptor Phosphorylation and InternalizationAmerican Journal of Respiratory Cell and Molecular Biology, 2007
- Visualization of Agonist-induced Sequestration and Down-regulation of a Green Fluorescent Protein-tagged β2-Adrenergic ReceptorJournal of Biological Chemistry, 1998